Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Morning Review
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Transcripts
  • inderesTV
  • Portfolio
  • Forum
  • Q&A
  • About Us
    • Our Coverage
    • Team

Morning review

Monday 2026-03-02
Companies

Morning topics

Lassila & Tikanoja Q4'25: Q4-raportti vastasi odotuksiamme, arvostus yhä halpa
Buy
(previously: Buy)
Priset på svart guld steg på grund av problem i Hormuzsundet
Article
Luotea Q4'25: Vinsttillväxten bör fortsätta trots ett svagt Q4
Accumulate
(previously: Accumulate)
Sunborn International H2'25: Balansräkningens tyngd bromsar tillväxtvågen
Reduce
(previously: Sell)
Rebl Group Q4'25: Utsikterna är försiktigt positiva
Reduce
(previously: Reduce)
Tamtron H2’25 förhandskommentar: Starka siffror förväntas, fokus på utsikterna
Buy
Herantis H2'25 preview: Blood-brain barrier passed and financial barriers lowered
Reduce
Market review
OMX Stockholm 30
3,223
+0.55%
OMX Helsinki 25
6,148
+0.93%
OMX Copenhagen 25
1,731
+0.14%
DAX
25,284
-0.02%
STOXX Europe 600
633.8
+0.11%
SSE Comp.
4,189
+0.62%
Nikkei 225
57,872
-1.66%
SEK/EUR
0.094
-0.03%
SEK/USD
0.11
-0.12%
Gainers
Neovici Holding B5.98 SEK
+52.16%
Norske Skog
28.20 NOK
+20.77%
Simris Group B0.10 SEK
+19.05%
Heliospectra0.11 SEK
+14.87%
Promimic11.00 SEK
+13.17%
Losers
Scandinavian Enviro Systems0.14 SEK
-46.28%
Chordate Medical Holding Pref
0.36 SEK
-32.59%
Chordate Medical Holding
0.22 SEK
-30.50%
Rolling Optics Holding0.23 SEK
-19.29%
OXE Marine0.27 SEK
-15.36%
Upcoming events
Mar 06
6 events
Mar 09
1 event
Mar 10
8 events
Mar 11
6 events
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.